CureVac N.V. is a German biopharmaceutical company. It develops therapies based on messenger RNA (mRNA). Headquartered in Tübingen, Germany, the company...
29 KB (2,394 words) - 19:29, 12 September 2024
The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness...
19 KB (1,571 words) - 07:31, 10 May 2024
concerning the use of RNA and is a founder of the German biotechnology company CureVac. He created the initial technology used in RNA vaccines and has reportedly...
14 KB (1,504 words) - 05:01, 7 September 2024
including Deutsche Post, Deutsche Telekom, Commerzbank, Lufthansa, and CureVac. In 2013, KfW agreed to help establish a Portuguese financial institution...
15 KB (1,480 words) - 20:57, 4 August 2024
additional companies such as Viacyte (part of Vertex), Nkarta, Capsida, Curevac, and others. CRISPR Therapeutics has drugs approved and in development...
11 KB (918 words) - 14:13, 19 April 2024
Moderna, AstraZeneca, and Janssen. Iceland has also signed a contract with CureVac. Iceland signed a contract on December 9, 2020, with Pfizer, and a contract...
26 KB (1,636 words) - 20:36, 16 May 2024
EU-gemensamt avtal om covid-19-vaccin med CureVac" [Sweden joins the collective EU COVID-19 vaccine contract with CureVac] (Press release) (in Swedish). Ministry...
34 KB (2,136 words) - 10:01, 6 September 2024
Behring (subsidiary of CSL; 1904– ) CSPC (1992- ) CSPC Zhongrun (1989– ) CureVac (2000– ) Cyclacel (1997– ) Cytokinetics (1997– ) CytRx (1985– ) Daewoong...
34 KB (2,175 words) - 05:58, 20 September 2024
Janssen J&J 11 March 2021 April 2021 Novavax 20 December 2021 Pending Valneva Pending Pending Sanofi–GSK Pending Pending CureVac Request withdrawn No...
101 KB (8,794 words) - 10:32, 7 September 2024
(€955 million). In July 2020, GSK acquired a 10% stake in German biotech company CureVac. In March 2018, GSK announced that it has reached an agreement with Novartis...
135 KB (12,154 words) - 20:32, 12 September 2024